Objective To explore the role of clinical pharmacists in the treatment of liver injury in tumor patients,and to provide reference for the involvement of clinical pharmacists in clinical practice.Methods Clinical pharmacists participated in the treatment of one case of acute liver injury caused by irinotecan in a colon cancer patient,analyzed the causes of acute liver injury,assessed the causal relationship between the drug and liver injury using the Roussel Uclaf Causality Assessment Method(RUCAM),and adjusted the treatment with liver-protecting drugs.Results By analyzing the correlation between acute liver injury and diseases and drugs,clinical pharmacists quickly recommended optimization of the treatment with liver-protecting drugs,and provided pharmaceutical care for the patient.After treatment,the patient's liver function was significantly improved.Conclusion Prudent pharmacological monitoring of patients under chemotherapy by clinical pharmacists can help to reduce the incidence of adverse reactions,optimize the effect of drug therapy,and improve the level of rational clinical use of drugs.
irinotecanliver injurycolon canceradverse drug reactionpharmaceutical careclinical pharmacist
维普
万方数据
